Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender

Background. Circulating adiponectin has been suggested to be associated with atrial fibrillation (AF). However, whether the association differs by age and gender remains unknown. We performed a case-control study to evaluate the above association. Methods. AF patients who underwent 24-hour long-rang...

Full description

Saved in:
Bibliographic Details
Main Authors: Tongjian Zhu, Zhuo Wang, Songyun Wang, Wei Hu, Hui Chen, Jing Xie, Meng Wang, Kezhong Ma, Hong Jiang
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/6633948
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555229905682432
author Tongjian Zhu
Zhuo Wang
Songyun Wang
Wei Hu
Hui Chen
Jing Xie
Meng Wang
Kezhong Ma
Hong Jiang
author_facet Tongjian Zhu
Zhuo Wang
Songyun Wang
Wei Hu
Hui Chen
Jing Xie
Meng Wang
Kezhong Ma
Hong Jiang
author_sort Tongjian Zhu
collection DOAJ
description Background. Circulating adiponectin has been suggested to be associated with atrial fibrillation (AF). However, whether the association differs by age and gender remains unknown. We performed a case-control study to evaluate the above association. Methods. AF patients who underwent 24-hour long-range 12-channel electrocardiogram examination at our center were included in this study, and people with normal sinus rhythm (NSR) were included as controls. All participants underwent echocardiography and heart rate variability tests. Biochemical parameters and adiponectin levels were also evaluated. Receiver operating characteristic (ROC) analyses were used to determine the predictive efficacy of adiponectin for AF, and multivariate logistic regression analysis was performed to evaluate the potential independent predictors of AF. Results. Overall, 84 patients with AF and 84 people with NSR were included. Serum adiponectin was significantly higher in AF patients compared to that in controls (P<0.001). ROC analysis showed that higher serum adiponectin (>6.098 μg/mL) had predictive efficacy for AF, with an area under the curve of 0.660 (95% confidence interval [CI]: 577–0.742). The results of multivariate logistic regression analysis showed that higher adiponectin was an independent predictor of AF in the overall participants (odds ratio [OR] 1.224, 95% CI 1.018–1.471, P=0.032). Subgroup analysis showed that higher adiponectin was independently associated with AF in women (OR 1.893, 95% CI 1.160–3.089, P=0.011) and in patients aged < 65 years (OR 1.453, 95% CI 1.023–2.064, P=0.037), but not in men or those aged ≥ 65 years. Conclusions. Higher serum adiponectin level was independently associated with higher odds for AF in women and in participants <65 years old, but not in men or those aged ≥65 years.
format Article
id doaj-art-e44f0ddbc681499d9677296c0d6cac51
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-e44f0ddbc681499d9677296c0d6cac512025-02-03T05:49:18ZengWileyCardiology Research and Practice2090-80162090-05972021-01-01202110.1155/2021/66339486633948Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and GenderTongjian Zhu0Zhuo Wang1Songyun Wang2Wei Hu3Hui Chen4Jing Xie5Meng Wang6Kezhong Ma7Hong Jiang8Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei, ChinaBackground. Circulating adiponectin has been suggested to be associated with atrial fibrillation (AF). However, whether the association differs by age and gender remains unknown. We performed a case-control study to evaluate the above association. Methods. AF patients who underwent 24-hour long-range 12-channel electrocardiogram examination at our center were included in this study, and people with normal sinus rhythm (NSR) were included as controls. All participants underwent echocardiography and heart rate variability tests. Biochemical parameters and adiponectin levels were also evaluated. Receiver operating characteristic (ROC) analyses were used to determine the predictive efficacy of adiponectin for AF, and multivariate logistic regression analysis was performed to evaluate the potential independent predictors of AF. Results. Overall, 84 patients with AF and 84 people with NSR were included. Serum adiponectin was significantly higher in AF patients compared to that in controls (P<0.001). ROC analysis showed that higher serum adiponectin (>6.098 μg/mL) had predictive efficacy for AF, with an area under the curve of 0.660 (95% confidence interval [CI]: 577–0.742). The results of multivariate logistic regression analysis showed that higher adiponectin was an independent predictor of AF in the overall participants (odds ratio [OR] 1.224, 95% CI 1.018–1.471, P=0.032). Subgroup analysis showed that higher adiponectin was independently associated with AF in women (OR 1.893, 95% CI 1.160–3.089, P=0.011) and in patients aged < 65 years (OR 1.453, 95% CI 1.023–2.064, P=0.037), but not in men or those aged ≥ 65 years. Conclusions. Higher serum adiponectin level was independently associated with higher odds for AF in women and in participants <65 years old, but not in men or those aged ≥65 years.http://dx.doi.org/10.1155/2021/6633948
spellingShingle Tongjian Zhu
Zhuo Wang
Songyun Wang
Wei Hu
Hui Chen
Jing Xie
Meng Wang
Kezhong Ma
Hong Jiang
Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
Cardiology Research and Practice
title Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
title_full Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
title_fullStr Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
title_full_unstemmed Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
title_short Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender
title_sort association between serum adiponectin and atrial fibrillation a case control study stratified by age and gender
url http://dx.doi.org/10.1155/2021/6633948
work_keys_str_mv AT tongjianzhu associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT zhuowang associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT songyunwang associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT weihu associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT huichen associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT jingxie associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT mengwang associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT kezhongma associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender
AT hongjiang associationbetweenserumadiponectinandatrialfibrillationacasecontrolstudystratifiedbyageandgender